APO Research
Talk to an analyst

APO RESEARCH · REPORT

Closed Drug Transfer Systems

Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.

Selected research

Market Analysis & Forecast

Global Closed Drug Transfer Systems Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchClosed Drug Transfer Systems Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Closed Drug Transfer Systems Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Closed Drug Transfer Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Closed Drug Transfer Systems Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Closed Drug Transfer Systems Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.

North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.

Report Includes

Read the full market overview

This report presents an overview of global market for Closed Drug Transfer Systems, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Closed Drug Transfer Systems, also provides the revenue of main regions and countries. Of the upcoming market potential for Closed Drug Transfer Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Closed Drug Transfer Systems revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Closed Drug Transfer Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Closed Drug Transfer Systems revenue, projected growth trends, production technology, application and end-user industry.

Closed Drug Transfer Systems Segment by Company

BD Medical, Inc

Equashield, LLC

ICU Medical, Inc

Teva Medical Ltd

Corvida Medical

Closed Drug Transfer Systems Segment by Type

Closed Vial Access Devices

Closed Syringe Safety Devices

Closed Bag/Line Access Devices

Closed Drug Transfer Systems Segment by Application

Hospital

Clinic

Closed Drug Transfer Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Closed Drug Transfer Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Closed Drug Transfer Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Closed Drug Transfer Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Closed Drug Transfer Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Closed Drug Transfer Systems company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Closed Drug Transfer Systems revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Closed Drug Transfer Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Closed Vial Access Devices Major Player Table 3. Closed Syringe Safety Devices Major Player Table 4. Closed Bag/Line Access Devices Major Player Table 5. Global Closed Drug Transfer Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Clinic Major Player Table 8. Closed Drug Transfer Systems Industry Trends Table 9. Closed Drug Transfer Systems Industry Drivers Table 10. Closed Drug Transfer Systems Industry Opportunities and Challenges Table 11. Closed Drug Transfer Systems Industry Restraints Table 12. Global Closed Drug Transfer Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Closed Drug Transfer Systems Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Closed Drug Transfer Systems Market Share by Region (2021-2026) Table 15. Global Closed Drug Transfer Systems Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Closed Drug Transfer Systems Market Share by Region (2027-2032) Table 17. Global Closed Drug Transfer Systems Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Closed Drug Transfer Systems Revenue Market Share by Players (2021-2026) Table 19. Global Closed Drug Transfer Systems Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Closed Drug Transfer Systems Key Players Headquarters & Area Served Table 21. Global Closed Drug Transfer Systems Players, Product Type & Application Table 22. Global Closed Drug Transfer Systems Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Closed Drug Transfer Systems by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Closed Drug Transfer Systems Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Closed Drug Transfer Systems Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Closed Drug Transfer Systems Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Closed Drug Transfer Systems Revenue Market Share by Type (2021-2026) Table 29. Global Closed Drug Transfer Systems Revenue Market Share by Type (2027-2032) Table 30. Global Closed Drug Transfer Systems Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Closed Drug Transfer Systems Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Closed Drug Transfer Systems Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Closed Drug Transfer Systems Revenue Market Share by Application (2021-2026) Table 34. Global Closed Drug Transfer Systems Revenue Market Share by Application (2027-2032) Table 35. BD Medical, Inc Company Information Table 36. BD Medical, Inc Business Overview Table 37. BD Medical, Inc Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. BD Medical, Inc Closed Drug Transfer Systems Product Portfolio Table 39. BD Medical, Inc Recent Development Table 40. Equashield, LLC Company Information Table 41. Equashield, LLC Business Overview Table 42. Equashield, LLC Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Equashield, LLC Closed Drug Transfer Systems Product Portfolio Table 44. Equashield, LLC Recent Development Table 45. ICU Medical, Inc Company Information Table 46. ICU Medical, Inc Business Overview Table 47. ICU Medical, Inc Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. ICU Medical, Inc Closed Drug Transfer Systems Product Portfolio Table 49. ICU Medical, Inc Recent Development Table 50. Teva Medical Ltd Company Information Table 51. Teva Medical Ltd Business Overview Table 52. Teva Medical Ltd Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Teva Medical Ltd Closed Drug Transfer Systems Product Portfolio Table 54. Teva Medical Ltd Recent Development Table 55. Corvida Medical Company Information Table 56. Corvida Medical Business Overview Table 57. Corvida Medical Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Corvida Medical Closed Drug Transfer Systems Product Portfolio Table 59. Corvida Medical Recent Development Table 60. North America Closed Drug Transfer Systems Revenue by Type (2021-2026) & (US$ Million) Table 61. North America Closed Drug Transfer Systems Revenue by Type (2027-2032) & (US$ Million) Table 62. North America Closed Drug Transfer Systems Revenue by Application (2021-2026) & (US$ Million) Table 63. North America Closed Drug Transfer Systems Revenue by Application (2027-2032) & (US$ Million) Table 64. North America Closed Drug Transfer Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 65. North America Closed Drug Transfer Systems Revenue by Country (2021-2026) & (US$ Million) Table 66. North America Closed Drug Transfer Systems Revenue by Country (US$ Million) & (2027-2032) Table 67. Europe Closed Drug Transfer Systems Revenue by Type (2021-2026) & (US$ Million) Table 68. Europe Closed Drug Transfer Systems Revenue by Type (2027-2032) & (US$ Million) Table 69. Europe Closed Drug Transfer Systems Revenue by Application (2021-2026) & (US$ Million) Table 70. Europe Closed Drug Transfer Systems Revenue by Application (2027-2032) & (US$ Million) Table 71. Europe Closed Drug Transfer Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Europe Closed Drug Transfer Systems Revenue by Country (2021-2026) & (US$ Million) Table 73. Europe Closed Drug Transfer Systems Revenue by Country (US$ Million) & (2027-2032) Table 74. China Closed Drug Transfer Systems Revenue by Type (2021-2026) & (US$ Million) Table 75. China Closed Drug Transfer Systems Revenue by Type (2027-2032) & (US$ Million) Table 76. China Closed Drug Transfer Systems Revenue by Application (2021-2026) & (US$ Million) Table 77. China Closed Drug Transfer Systems Revenue by Application (2027-2032) & (US$ Million) Table 78. Asia Closed Drug Transfer Systems Revenue by Type (2021-2026) & (US$ Million) Table 79. Asia Closed Drug Transfer Systems Revenue by Type (2027-2032) & (US$ Million) Table 80. Asia Closed Drug Transfer Systems Revenue by Application (2021-2026) & (US$ Million) Table 81. Asia Closed Drug Transfer Systems Revenue by Application (2027-2032) & (US$ Million) Table 82. Asia Closed Drug Transfer Systems Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Asia Closed Drug Transfer Systems Revenue by Region (US$ Million) & (2021-2026) Table 84. Asia Closed Drug Transfer Systems Revenue by Region (US$ Million) & (2027-2032) Table 85. SAMEA Closed Drug Transfer Systems Revenue by Type (2021-2026) & (US$ Million) Table 86. SAMEA Closed Drug Transfer Systems Revenue by Type (2027-2032) & (US$ Million) Table 87. SAMEA Closed Drug Transfer Systems Revenue by Application (2021-2026) & (US$ Million) Table 88. SAMEA Closed Drug Transfer Systems Revenue by Application (2027-2032) & (US$ Million) Table 89. SAMEA Closed Drug Transfer Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. SAMEA Closed Drug Transfer Systems Revenue by Country (2021-2026) & (US$ Million) Table 91. SAMEA Closed Drug Transfer Systems Revenue by Country (US$ Million) & (2027-2032) Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Closed Drug Transfer Systems Image Figure 2. Global Closed Drug Transfer Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Closed Drug Transfer Systems Market Size Share 2021 VS 2025 VS 2032 Figure 4. Closed Vial Access Devices Image Figure 5. Closed Syringe Safety Devices Image Figure 6. Closed Bag/Line Access Devices Image Figure 7. Global Closed Drug Transfer Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Closed Drug Transfer Systems Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Global Closed Drug Transfer Systems Market Size (US$ Million) & (2021-2032) Figure 12. Global Closed Drug Transfer Systems Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Closed Drug Transfer Systems Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Closed Drug Transfer Systems Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Closed Drug Transfer Systems Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Closed Drug Transfer Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Closed Drug Transfer Systems Revenue Market Share by Type (2021-2032) Figure 19. Global Closed Drug Transfer Systems Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Closed Drug Transfer Systems Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Closed Drug Transfer Systems Revenue Market Share by Application (2021-2032) Figure 22. North America Closed Drug Transfer Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Closed Drug Transfer Systems Revenue Share by Type (2021-2032) Figure 24. North America Closed Drug Transfer Systems Revenue Share by Application (2021-2032) Figure 25. North America Closed Drug Transfer Systems Revenue Share by Country (2021-2032) Figure 26. United States Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Closed Drug Transfer Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Closed Drug Transfer Systems Revenue Share by Type (2021-2032) Figure 31. Europe Closed Drug Transfer Systems Revenue Share by Application (2021-2032) Figure 32. Europe Closed Drug Transfer Systems Revenue Share by Country (2021-2032) Figure 33. Germany Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Closed Drug Transfer Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Closed Drug Transfer Systems Revenue Share by Type (2021-2032) Figure 43. China Closed Drug Transfer Systems Revenue Share by Application (2021-2032) Figure 44. Asia Closed Drug Transfer Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Closed Drug Transfer Systems Revenue Share by Type (2021-2032) Figure 46. Asia Closed Drug Transfer Systems Revenue Share by Application (2021-2032) Figure 47. Asia Closed Drug Transfer Systems Revenue Share by Region (2021-2032) Figure 48. Japan Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Closed Drug Transfer Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Closed Drug Transfer Systems Revenue Share by Type (2021-2032) Figure 56. SAMEA Closed Drug Transfer Systems Revenue Share by Application (2021-2032) Figure 57. SAMEA Closed Drug Transfer Systems Revenue Share by Country (2021-2032) Figure 58. Brazil Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Closed Drug Transfer Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Closed Vial Access Devices
  • Closed Syringe Safety Devices
  • Closed Bag/Line Access Devices
Applications
  • Hospital
  • Clinic
Companies covered
  • BD Medical, Inc
  • Equashield, LLC
  • ICU Medical, Inc
  • Teva Medical Ltd
  • Corvida Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Closed Drug Transfer Systems Market by Type
  3. 1.2.1 Global Closed Drug Transfer Systems Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Closed Vial Access Devices
  5. 1.2.3 Closed Syringe Safety Devices
  6. 1.2.4 Closed Bag/Line Access Devices
  7. 1.3 Closed Drug Transfer Systems Market by Application
  8. 1.3.1 Global Closed Drug Transfer Systems Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Closed Drug Transfer Systems Market Dynamics
  1. 2.1 Closed Drug Transfer Systems Industry Trends
  2. 2.2 Closed Drug Transfer Systems Industry Drivers
  3. 2.3 Closed Drug Transfer Systems Industry Opportunities and Challenges
  4. 2.4 Closed Drug Transfer Systems Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Closed Drug Transfer Systems Market Perspective (2021-2032)
  2. 3.2 Global Closed Drug Transfer Systems Growth Trends by Region
  3. 3.2.1 Global Closed Drug Transfer Systems Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Closed Drug Transfer Systems Market Size by Region (2021-2026)
  5. 3.2.3 Global Closed Drug Transfer Systems Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Closed Drug Transfer Systems Revenue by Players
  2. 4.1.1 Global Closed Drug Transfer Systems Revenue by Players (2021-2026)
  3. 4.1.2 Global Closed Drug Transfer Systems Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Closed Drug Transfer Systems Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Closed Drug Transfer Systems Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Closed Drug Transfer Systems Key Players Headquarters & Area Served
  7. 4.4 Global Closed Drug Transfer Systems Players, Product Type & Application
  8. 4.5 Global Closed Drug Transfer Systems Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Closed Drug Transfer Systems Market CR5 and HHI
  11. 4.6.3 2025 Closed Drug Transfer Systems Tier 1, Tier 2, and Tier 3
5 Closed Drug Transfer Systems Market Size by Type
  1. 5.1 Global Closed Drug Transfer Systems Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Closed Drug Transfer Systems Revenue by Type (2021-2032)
  3. 5.3 Global Closed Drug Transfer Systems Revenue Market Share by Type (2021-2032)
6 Closed Drug Transfer Systems Market Size by Application
  1. 6.1 Global Closed Drug Transfer Systems Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Closed Drug Transfer Systems Revenue by Application (2021-2032)
  3. 6.3 Global Closed Drug Transfer Systems Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BD Medical, Inc
  2. 7.1.1 BD Medical, Inc Company Information
  3. 7.1.2 BD Medical, Inc Business Overview
  4. 7.1.3 BD Medical, Inc Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BD Medical, Inc Closed Drug Transfer Systems Product Portfolio
  6. 7.1.5 BD Medical, Inc Recent Developments
  7. 7.2 Equashield, LLC
  8. 7.2.1 Equashield, LLC Company Information
  9. 7.2.2 Equashield, LLC Business Overview
  10. 7.2.3 Equashield, LLC Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Equashield, LLC Closed Drug Transfer Systems Product Portfolio
  12. 7.2.5 Equashield, LLC Recent Developments
  13. 7.3 ICU Medical, Inc
  14. 7.3.1 ICU Medical, Inc Company Information
  15. 7.3.2 ICU Medical, Inc Business Overview
  16. 7.3.3 ICU Medical, Inc Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ICU Medical, Inc Closed Drug Transfer Systems Product Portfolio
  18. 7.3.5 ICU Medical, Inc Recent Developments
  19. 7.4 Teva Medical Ltd
  20. 7.4.1 Teva Medical Ltd Company Information
  21. 7.4.2 Teva Medical Ltd Business Overview
  22. 7.4.3 Teva Medical Ltd Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Teva Medical Ltd Closed Drug Transfer Systems Product Portfolio
  24. 7.4.5 Teva Medical Ltd Recent Developments
  25. 7.5 Corvida Medical
  26. 7.5.1 Corvida Medical Company Information
  27. 7.5.2 Corvida Medical Business Overview
  28. 7.5.3 Corvida Medical Closed Drug Transfer Systems Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Corvida Medical Closed Drug Transfer Systems Product Portfolio
  30. 7.5.5 Corvida Medical Recent Developments
8 North America
  1. 8.1 North America Closed Drug Transfer Systems Revenue (2021-2032)
  2. 8.2 North America Closed Drug Transfer Systems Revenue by Type (2021-2032)
  3. 8.2.1 North America Closed Drug Transfer Systems Revenue by Type (2021-2026)
  4. 8.2.2 North America Closed Drug Transfer Systems Revenue by Type (2027-2032)
  5. 8.3 North America Closed Drug Transfer Systems Revenue Share by Type (2021-2032)
  6. 8.4 North America Closed Drug Transfer Systems Revenue by Application (2021-2032)
  7. 8.4.1 North America Closed Drug Transfer Systems Revenue by Application (2021-2026)
  8. 8.4.2 North America Closed Drug Transfer Systems Revenue by Application (2027-2032)
  9. 8.5 North America Closed Drug Transfer Systems Revenue Share by Application (2021-2032)
  10. 8.6 North America Closed Drug Transfer Systems Revenue by Country
  11. 8.6.1 North America Closed Drug Transfer Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Closed Drug Transfer Systems Revenue by Country (2021-2026)
  13. 8.6.3 North America Closed Drug Transfer Systems Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Closed Drug Transfer Systems Revenue (2021-2032)
  2. 9.2 Europe Closed Drug Transfer Systems Revenue by Type (2021-2032)
  3. 9.2.1 Europe Closed Drug Transfer Systems Revenue by Type (2021-2026)
  4. 9.2.2 Europe Closed Drug Transfer Systems Revenue by Type (2027-2032)
  5. 9.3 Europe Closed Drug Transfer Systems Revenue Share by Type (2021-2032)
  6. 9.4 Europe Closed Drug Transfer Systems Revenue by Application (2021-2032)
  7. 9.4.1 Europe Closed Drug Transfer Systems Revenue by Application (2021-2026)
  8. 9.4.2 Europe Closed Drug Transfer Systems Revenue by Application (2027-2032)
  9. 9.5 Europe Closed Drug Transfer Systems Revenue Share by Application (2021-2032)
  10. 9.6 Europe Closed Drug Transfer Systems Revenue by Country
  11. 9.6.1 Europe Closed Drug Transfer Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Closed Drug Transfer Systems Revenue by Country (2021-2026)
  13. 9.6.3 Europe Closed Drug Transfer Systems Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Closed Drug Transfer Systems Revenue (2021-2032)
  2. 10.2 China Closed Drug Transfer Systems Revenue by Type (2021-2032)
  3. 10.2.1 China Closed Drug Transfer Systems Revenue by Type (2021-2026)
  4. 10.2.2 China Closed Drug Transfer Systems Revenue by Type (2027-2032)
  5. 10.3 China Closed Drug Transfer Systems Revenue Share by Type (2021-2032)
  6. 10.4 China Closed Drug Transfer Systems Revenue by Application (2021-2032)
  7. 10.4.1 China Closed Drug Transfer Systems Revenue by Application (2021-2026)
  8. 10.4.2 China Closed Drug Transfer Systems Revenue by Application (2027-2032)
  9. 10.5 China Closed Drug Transfer Systems Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Closed Drug Transfer Systems Revenue (2021-2032)
  2. 11.2 Asia Closed Drug Transfer Systems Revenue by Type (2021-2032)
  3. 11.2.1 Asia Closed Drug Transfer Systems Revenue by Type (2021-2026)
  4. 11.2.2 Asia Closed Drug Transfer Systems Revenue by Type (2027-2032)
  5. 11.3 Asia Closed Drug Transfer Systems Revenue Share by Type (2021-2032)
  6. 11.4 Asia Closed Drug Transfer Systems Revenue by Application (2021-2032)
  7. 11.4.1 Asia Closed Drug Transfer Systems Revenue by Application (2021-2026)
  8. 11.4.2 Asia Closed Drug Transfer Systems Revenue by Application (2027-2032)
  9. 11.5 Asia Closed Drug Transfer Systems Revenue Share by Application (2021-2032)
  10. 11.6 Asia Closed Drug Transfer Systems Revenue by Country
  11. 11.6.1 Asia Closed Drug Transfer Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Closed Drug Transfer Systems Revenue by Country (2021-2026)
  13. 11.6.3 Asia Closed Drug Transfer Systems Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Closed Drug Transfer Systems Revenue (2021-2032)
  2. 12.2 SAMEA Closed Drug Transfer Systems Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Closed Drug Transfer Systems Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Closed Drug Transfer Systems Revenue by Type (2027-2032)
  5. 12.3 SAMEA Closed Drug Transfer Systems Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Closed Drug Transfer Systems Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Closed Drug Transfer Systems Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Closed Drug Transfer Systems Revenue by Application (2027-2032)
  9. 12.5 SAMEA Closed Drug Transfer Systems Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Closed Drug Transfer Systems Revenue by Country
  11. 12.6.1 SAMEA Closed Drug Transfer Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Closed Drug Transfer Systems Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Closed Drug Transfer Systems Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst